stockrow
Friday 6 November 2026
Export DCTH’s income statement to Excel — free account
Delcath Systems, Inc.
DCTH Healthcare Medical Devices
Delcath Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $85.2 million, up 129.1% from fiscal 2024.
- Revenue
- +20.6%
- EPS
- −12.5%
- Free cash flow
- −24.5%
Quarter to June 2026, against a year earlier
14.99
0.50
+3.45%
Follow DCTH
Alert me
Delcath Systems, Inc. (DCTH) P/E ratio
As of 6 November 2026, Delcath Systems, Inc. (DCTH) trades at a P/E ratio of 1,499×. Over the past ten years it has ranged from 0.0× (June 2025) to 1,736× (August 2026); the current reading is higher than 98% of that period. That is above the Medical Devices industry median of 25.6× and above the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 126× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 1,259× | 171.34% |
| Mar 2026 | 464× | 267.52% |
| Dec 2025 | 126× | (76.51%) |
| Sep 2025 | 538× | 137.13% |
| 42 more quarters | Free account |
Against its own ten years
Low 0.0×
High 1,736×
Ten-year median
0.0×
Current reading's percentile
98
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| SENS Senseonics Holdings, Inc. compare | n/m |
| SGHT Sight Sciences, Inc. compare | n/m |
| CERS Cerus Corporation compare | n/m |
| SSII SS Innovations International, Inc. compare | n/m |
| AVR Anteris Technologies Global Corp. compare | n/m |
| NPCE NeuroPace, Inc. compare | n/m |
| MASS 908 Devices Inc. compare | n/m |
| BWAY Brainsway Ltd. Sponsored ADR compare | 21.2× |
| DCTH Delcath Systems, Inc. | 1,455× |
| Medical Devices industry median | 25.6× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)